T2 Biosystems implements 1-for-100 reverse stock split; trading begins Oct 13

T2 Biosystems, Inc.

Reverse split ratio of 1-for-100 approved by Board on Oct 10, 2023.
Amendment filed with Delaware Secretary of State on Oct 12, 2023; effective same date.
Common stock will trade on Nasdaq on split-adjusted basis on Oct 13, 2023 under ticker TTOO.
No fractional shares; cash payment based on Oct 12 closing price for fractional interests.
New CUSIP number is 89853L 302.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

T2 Biosystems, Inc.: Filed a certificate of amendment to the Certificate of Incorporation to effect a 1-for-100 reverse stock split, approved by the Board on October 10, 2023 (effective 2023-10-12).

Change: charter amendment
Effective: 2023-10-12

Exact text from the filing

On October 12, 2023, the Company filed a certificate of amendment to the Certificate of Incorporation (the “Amendment”) with the Office of the Secretary of State of the State of Delaware to effect the Reverse Stock Split

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001193125-23-254974

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.